Short answer
BrightSpring Health Services, Inc. (BTSG) filed its Q3 2026 10-Q quarterly report on Oct 30, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $4.2B (up 26.4% year over year) with net income of $100M.
Q3 2026 key financials · XBRL
- Revenue
- $4.2B
- +26.4% YoY · +8.8% QoQ
- Net income
- $100M
- +79.3% YoY · +18.8% QoQ
- Operating margin
- 3.8%
- Gross margin
- 12.3%
- EPS (diluted)
- $0.46
- +84.0% YoY · +21.1% QoQ
Source: XBRL data from the BrightSpring Health Services, Inc. (BTSG) Q3 2026 10-Q on SEC EDGAR. USD.
BrightSpring Health Services, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $4,213.2M, up $879.1M or 26.4% YoY
- Gross margin 12.3% vs 11.8% YoY, operating margin 3.8% vs 2.6%
- Best segment: Pharmacy Solutions revenue $3,732.4M, up 25.8%; EBITDA $202.0M, up 43.3%
- Worst product line: Home and Community Pharmacy revenue $552.6M, down $37.4M or 6.3%
- Cash $717.8M, operating cash flow $371.2M; $300.0M debt repayment and $120.0M share repurchases disclosed
Risk Factors
- Healthcare regulatory and compliance risk: 2025 10-K risk factors remain unchanged
- Operational risk: Business disruption risks carried forward from the 2025 10-K
- Financial risk: Financial-condition risks carried forward from the 2025 10-K
- Unknown-risk exposure: Unidentified or currently immaterial risks could materially harm results
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other BrightSpring Health Services, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.